Bilirubin and jaundice in the micropremie.
Although it has been customary to treat neonatal jaundice at lower serum bilirubin levels in low-birth weight infants than in term infants, the threshold bilirubin levels and long-term benefits for early treatment of preterm infants have not been validated. This article summarizes and evaluates existing evidence and strategies for early treatment of bilirubin in micropremies and recommends a conservative but flexible approach to early monitoring and phototherapy for jaundice in extremely low-birth weight infants.
Cashore
W J
WJ
Department of Pediatrics, Women & Infants Hospital of Rhode Island, Brown University School of Medicine, Providence, USA.
D001663:Bilirubin / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D019102:Infant, Very Low Birth Weight / Q000378:metabolism*; D007567:Jaundice, Neonatal / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D010789:Phototherapy
D001663:Bilirubin